OCI N.V (OCI) | Financial Analysis & Statements
OCI N.V. Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2024Income Metrics
Revenue
494.9M
Gross Profit
58.7M
11.86%
Operating Income
-28.4M
-5.74%
Net Income
59.1M
11.94%
EPS (Diluted)
€-0.08
Balance Sheet Metrics
Total Assets
1.8B
Total Liabilities
764.6M
Shareholders Equity
1.1B
Debt to Equity
0.71
Cash Flow Metrics
Operating Cash Flow
-6.2M
Free Cash Flow
65.1M
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2024
Annual Income Flow
2025
OCI N.V Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.1B | 975.1M | 946.7M | 3.7B | 6.3B |
| Cost of Goods Sold | 1.1B | 973.1M | 1.0B | 3.3B | 4.5B |
| Gross Profit | 23.7M | 2.0M | -87.6M | 422.2M | 1.8B |
| Gross Margin % | 2.2% | 0.2% | -9.3% | 11.4% | 28.9% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 171.7M | 231.9M | 132.9M | 161.9M | 266.4M |
| Other Operating Expenses | 100.0K | 7.0M | 67.8M | 200.0K | 1.2M |
| Total Operating Expenses | 171.8M | 238.9M | 200.7M | 162.1M | 267.6M |
| Operating Income | -148.1M | -236.9M | -288.3M | 260.1M | 1.6B |
| Operating Margin % | -13.6% | -24.3% | -30.5% | 7.0% | 24.7% |
| Non-Operating Items | |||||
| Interest Income | 54.7M | 54.3M | 6.1M | 4.7M | 4.0M |
| Interest Expense | 47.6M | 89.3M | 60.7M | 22.7M | 281.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -356.6M | -157.5M | -298.6M | 364.6M | 1.3B |
| Income Tax | -12.9M | 7.6M | -37.4M | 47.3M | 137.1M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 13.0% | 10.6% |
| Net Income | 183.8M | 5.2B | -86.5M | 2.4B | 1.2B |
| Net Margin % | 16.9% | 532.9% | -9.1% | 65.3% | 18.3% |
| Key Metrics | |||||
| EBITDA | -147.1M | 48.9M | -153.2M | 536.9M | 2.5B |
| EPS (Basic) | - | €23.59 | €-1.86 | €5.89 | €2.72 |
| EPS (Diluted) | - | €23.53 | €-1.86 | €5.85 | €2.70 |
| Basic Shares Outstanding | - | 211042635 | 210639441 | 210274265 | 215473768 |
| Diluted Shares Outstanding | - | 211042635 | 210639441 | 210274265 | 215473768 |
Income Statement Trend
OCI N.V Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 17.9M | 2.1B | 100.3M | 1.7B | 1.4B |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 671.6M | 658.8M | 365.5M | 820.2M | 851.6M |
| Inventory | 67.5M | 138.0M | 155.9M | 421.4M | 343.5M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 896.4M | 3.8B | 7.1B | 3.0B | 2.8B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 13.5M | 49.0M | 47.1M | 63.2M | 60.7M |
| Goodwill | 7.2M | 39.3M | 101.7M | 974.5M | 969.9M |
| Intangible Assets | - | 500.0K | 14.5M | 8.5M | 1.5M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 943.0M | 561.4M | 1.9B | 6.8B | 7.0B |
| Total Assets | 1.8B | 4.3B | 9.0B | 9.8B | 9.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 521.1M | 956.1M | 671.3M | 1.3B | 1.4B |
| Short-term Debt | 72.5M | 701.5M | 202.3M | 352.0M | 550.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 670.7M | 1.9B | 4.8B | 2.0B | 2.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 82.8M | 102.2M | 2.1B | 2.8B | 3.5B |
| Deferred Tax Liabilities | 100.0K | 4.2M | 14.2M | 485.3M | 614.4M |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | 93.9M | 141.8M | 2.3B | 3.4B | 4.2B |
| Total Liabilities | 764.6M | 2.1B | 7.0B | 5.4B | 6.3B |
| Equity | |||||
| Common Stock | 5.6M | 5.6M | 5.6M | 5.6M | 5.6M |
| Retained Earnings | 128.3M | 147.7M | -3.1B | -2.5B | -3.9B |
| Treasury Stock | 7.9M | 10.6M | 7.4M | 11.0M | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.1B | 2.2B | 2.0B | 4.3B | 3.5B |
| Key Metrics | |||||
| Total Debt | 155.3M | 803.7M | 2.3B | 3.2B | 4.1B |
| Working Capital | 225.7M | 1.8B | 2.4B | 945.9M | 654.0M |
Balance Sheet Composition
OCI N.V Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -343.7M | -165.1M | -261.2M | 317.3M | 1.2B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 2.0M | 10.6M | 11.2M | 9.2M | 8.5M |
| Working Capital Changes | -57.9M | -579.2M | -142.4M | -109.8M | -319.0M |
| Operating Cash Flow | -334.2M | -698.7M | -337.8M | 211.3M | 1.1B |
| Investing Activities | |||||
| Capital Expenditures | -120.2M | -76.3M | -161.8M | -242.4M | -246.2M |
| Acquisitions | -584.2M | -155.3M | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | 1.3B | 8.7B | 0 | - | - |
| Investing Cash Flow | 497.3M | 7.9B | -774.3M | -392.6M | -246.2M |
| Financing Activities | |||||
| Share Repurchases | -1.0M | -7.8M | 0 | -200.0K | -1.0M |
| Dividends Paid | -1.7B | -3.2B | -986.2M | -1.1B | - |
| Debt Issuance | 98.2M | 967.1M | 1.7B | 148.2M | 2.2B |
| Debt Repayment | -776.7M | -2.3B | -541.8M | -407.2M | -3.2B |
| Financing Cash Flow | -2.4B | -6.0B | -771.4M | -2.3B | -132.4M |
| Free Cash Flow | -202.4M | 147.1M | 530.8M | 3.1B | 2.0B |
| Net Change in Cash | -2.2B | 1.2B | -1.9B | -2.5B | 746.4M |
Cash Flow Trend
OCI N.V Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
27.05
Forward P/E
75.87
Price to Book
0.84
Price to Sales
0.71
PEG Ratio
75.87
Profitability Ratios
Profit Margin
16.92%
Operating Margin
-3.80%
Return on Equity
-20.70%
Return on Assets
-2.90%
Financial Health
Current Ratio
1.34
Debt to Equity
14.45
Beta
0.32
Per Share Data
EPS (TTM)
€-1.39
Book Value per Share
€4.32
Revenue per Share
€5.15
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| OCI | 766.7M | 27.05 | 0.84 | -20.70% | 16.92% | 14.45 |
| DSM-Firmenich AG | 16.2B | 53.42 | 0.89 | 1.66% | -11.97% | 28.64 |
| Akzo Nobel N.V | 9.0B | 14.47 | 1.97 | 13.95% | 6.25% | 100.83 |
| IMCD N.V | 5.7B | 26.18 | 2.79 | 10.22% | 4.53% | 87.66 |
| Corbion N.V | 1.1B | 14.56 | 1.43 | 9.87% | 5.90% | 60.14 |
Financial data is updated regularly. All figures are in the company's reporting currency.